ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

NCI Supports Development Of Reinoids for Prevention; No Magic Bullet

May 6, 1977

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012

Clinical Trials Approved By NCI

January 30, 2004

Professional Societies: AACI Seeks To Define Role Of Cancer Centers In Washington Politics

October 16, 1998

NCI CTEP Approved Trials For the Month of October

October 25, 2013